Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Lymphoma, Follicular
×
ruxolitinib
×
Lymphoid
×
Clear all
Filters
3
NCT03774082
2025-12-11
REACH 5
Novartis
Phase 2
Completed
46 enrolled
21 charts
NCT04934670
2024-08-27
2002
Xenikos
Phase 3
Terminated
12 enrolled
12 charts